Page 97 - 南京医科大学学报自然科学版

第42卷第7期 陈晓超，卜恒涛，梁 超，等. m5C甲基化相关基因预测肾透明细胞癌的预后［J］.
2022年7月 南京医科大学学报（自然科学版），2022，42（7）：983-993 ·993 ·

of a set of genes improving survival prediction in kidney experimental datasets［J］. Nucleic Acids Res，2019，47
renal clear cell carcinoma through integrative reanalysis （D1）：D607-D613
of transcriptomic data［J］. Dis Markers，2020，2020： ［13］ HEISSENBERGER C，LIENDL L，NAGELREITER F，et
8824717 al. Loss of the ribosomal RNA methyltransferase NSUN5
［4］ RONG D W，SUN G S，WU F，et al. Epigenetics：roles impairs global protein synthesis and normal growth［J］.
and therapeutic implications of non⁃coding RNA modifi⁃ Nucleic Acids Res，2019，47（22）：11807-11825
cations in human cancers［J］. Mol Ther Nucleic Acids， ［14］ JIANG Z，LI S，HAN M J，et al. High expression of
2021，25：67-82
NSUN5 promotes cell proliferation via cell cycle regula⁃
［5］ WILKINSON E，CUI Y H，HE Y Y. Roles of RNA modifi⁃
tion in colorectal cancer［J］. Am J Transl Res，2020，12
cations in diverse cellular functions［J］. Front Cell Dev
（7）：3858-3870
Biol，2022，10：828683
［15］ YANG R，LIANG X，WANG H，et al. The RNA methyl⁃
［6］ PAN J F，HUANG Z D，XU Y Q. m5C RNA methylation
transferase NSUN6 suppresses pancreatic cancer develop⁃
regulators predict prognosis and regulate the immune mi⁃
ment by regulating cell proliferation［J］. EBioMedicine，
croenvironment in lung squamous cell carcinoma［J］.
2021，63：103195
Front Oncol，2021，11：657466
［16］ AWAH C U，WINTER J，MAZDOOM C M，et al. NSUN6，
［7］ CHEN X，LI A，SUN B F，et al. 5 ⁃ methylcytosine pro⁃
an RNA methyltransferase of 5⁃mC controls glioblastoma
motes pathogenesis of bladder cancer through stabilizing
response to temozolomide （TMZ） via NELFB and
mRNAs［J］. Nat Cell Biol，2019，21（8）：978-990
RPS6KB2 interaction［J］. Cancer Biol Ther，2021，22（10/
［8］ HAN Z，YANG B，WANG Y，et al. Identification of ex⁃
11/12）：587-597
pression patterns and potential prognostic significance of
［17］ ZHU A P，HOPKINS K M，FRIEDMAN R A，et al. DN⁃
m（5）C ⁃ related regulators in head and neck squamous
MT1 and DNMT3B regulate tumorigenicity of human
cell carcinoma［J］. Front Oncol，2021，11：592107
prostate cancer cells by controlling RAD9 expression
［9］ MOUNIR M，LUCCHETTA M，SILVA T C，et al. New
through targeted methylation［J］. Carcinogenesis，2021，
functionalities in the TCGA biolinks package for the
42（2）：220-231
study and integration of cancer data from GDC and GTEx
［18］ XU K，CHEN B，LI B，et al. DNMT3B silencing suppress⁃
［J］. PLoS Comput Biol，2019，15（3）：e1006701
es migration and invasion by epigenetically promoting miR⁃
［10］ ZHANG X K，WANG Y Y，A G R，et al. Pan⁃cancer analy⁃
34a in bladder cancer［J］. Aging，2020，12（23）：23668-
sis of PARP1 alterations as biomarkers in the prediction
23683
of immunotherapeutic effects and the association of its ex⁃
pression levels and immunotherapy signatures［J］. Front ［19］ PADDA J，KHALID K，YADAV J，et al. JAK2 and TET2
mutation in polycythemia vera［J］. Cureus，2021，13（9）：
Immunol，2021，12：721030
［11］ TANG Z F，KANG B X，LI C W，et al. GEPIA2：an en⁃ e17854
hanced web server for large ⁃ scale expression profiling ［20］ PENG B，LI C，HE L，et al. miR⁃660⁃5p promotes breast
and interactive analysis［J］. Nucleic Acids Res，2019，47 cancer progression through down⁃regulating TET2 and ac⁃
（W1）：W556-W560 tivating PI3K/AKT/mTOR signaling［J］. Braz J Med Biol
［12］ SZKLARCZYK D，GABLE A L，LYON D，et al. STRING Res，2020，53（12）：e9740
v11：protein⁃protein association networks with increased ［收稿日期］ 2022-04-18
coverage，supporting functional discovery in genome⁃wide （责任编辑：蒋 莉）